Weiss Multi-Strategy Advisers’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-12,000
| Closed | -$2.64M | – | 419 |
|
|
2023
Q4 | $2.64M | Buy |
12,000
+6,834
| +132% | +$1.5M | 0.06% | 305 |
|
|
2023
Q3 | $1.17M | Buy |
5,166
+473
| +10% | +$107K | 0.03% | 399 |
|
|
2023
Q2 | $1.04M | Buy |
4,693
+1,745
| +59% | +$385K | 0.02% | 498 |
|
|
2023
Q1 | $660K | Sell |
2,948
-52
| -2% | -$11.6K | 0.02% | 501 |
|
|
2022
Q4 | $834K | Sell |
3,000
-2,000
| -40% | -$556K | 0.02% | 464 |
|
|
2022
Q3 | $1.05M | Sell |
5,000
-1,500
| -23% | -$314K | 0.03% | 465 |
|
|
2022
Q2 | $1.53M | Sell |
6,500
-8,110
| -56% | -$1.91M | 0.05% | 421 |
|
|
2022
Q1 | $2.62M | Sell |
14,610
-3,929
| -21% | -$705K | 0.06% | 347 |
|
|
2021
Q4 | $4.01M | Sell |
18,539
-211
| -1% | -$45.6K | 0.09% | 276 |
|
|
2021
Q3 | $3.46M | Buy |
18,750
+1,750
| +10% | +$323K | 0.07% | 313 |
|
|
2021
Q2 | $3.05M | Sell |
17,000
-1,081
| -6% | -$194K | 0.07% | 332 |
|
|
2021
Q1 | $3.02M | Sell |
18,081
-480
| -3% | -$80.3K | 0.07% | 334 |
|
|
2020
Q4 | $2.82M | Sell |
18,561
-4,688
| -20% | -$711K | 0.05% | 333 |
|
|
2020
Q3 | $2.35M | Buy |
23,249
+3,749
| +19% | +$379K | 0.06% | 316 |
|
|
2020
Q2 | $2.36M | Buy |
19,500
+2,672
| +16% | +$323K | 0.07% | 294 |
|
|
2020
Q1 | $1.6M | Buy |
+16,828
| New | +$1.6M | 0.06% | 255 |
|
|
2014
Q4 | – | Hold |
0
| – | – | – | 493 |
|
|
2014
Q3 | – | Hold |
0
| – | – | – | 676 |
|
|
2014
Q2 | – | Sell |
-4,690
| Closed | -$441K | – | 844 |
|
|
2014
Q1 | $441K | Buy |
4,690
+600
| +15% | +$56.4K | 0.01% | 644 |
|
|
2013
Q4 | $462K | Buy |
4,090
+550
| +16% | +$62.1K | 0.01% | 606 |
|
|
2013
Q3 | $279K | Buy |
+3,540
| New | +$279K | 0.01% | 608 |
|